Read p7b05.m2f.pdf text version

Chronic Illnesses II Panel

Editorial Board Liaison

Michelle M. Richardson, Pharm.D., FCCP, BCPS Special and Scientific Staff William B. Schwartz Division of Nephrology Tufts Medical Center Assistant Professor of Medicine Tufts University School of Medicine Boston, Massachusetts Christopher Bernheisel, M.D. Assistant Professor The Christ Hospital University of Cincinnati Family Medicine Residency Program Director Department of Family and Community Medicine University of Cincinnati Cincinnati, Ohio Reviewers Henry Halapy, Pharm.D., CDE, CPT Clinical Pharmacy Specialist Diabetes and Osteoporosis Centre St. Michael's Hospital Toronto, Ontario, Canada Lisa C. Hutchison, Pharm.D., MPH, FCCP, BCPS Associate Professor Pharmacy Practice University of Arkansas for Medical Sciences Little Rock, Arkansas Michael J. Remkus, Pharm.D., BCPS Healthcare Advisor and Financial Manager Departments of International and Domestic Operations Importaciones J. Vivanco, SAC Lima, Peru

New Technologies for Managing Diabetes Mellitus

Author Lisa B. Cohen, Pharm.D., CDE Assistant Professor Department of Pharmacy Practice University of Rhode Island Kingston, Rhode Island Reviewers Christa M. George, Pharm.D., BCPS, CDE Associate Professor Department of Clinical Pharmacy University of Tennessee Health Science Center Memphis, Tennessee Brian A. Hemstreet, Pharm.D., BCPS Associate Professor Director, Pharmaceutical Care Learning Center Department of Clinical Pharmacy University of Colorado School of Pharmacy Aurora, Colorado

Pharmacovigilance and FDA Drug Safety Policy

Author Elaine H. Morrato, DrPH, MPH, CPH Assistant Professor Department of Health Systems, Management, and Policy Colorado School of Public Health Assistant Professor Department of Clinical Pharmacy School of Pharmacy Assistant Professor Department of Pediatrics School of Medicine University of Colorado Aurora, Colorado

New Guidelines, Recommendations, Warnings, and Drugs for Diabetes Mellitus

Authors Patricia R. Wigle, Pharm.D., BCPS Associate Professor Division of Pharmacy Practice and Administrative Sciences James L. Winkle College of Pharmacy University of Cincinnati Cincinnati, Ohio

PSAP-VII · Chronic Illnesses


Chronic Illnesses II

Reviewers Kimberli M. Burgner, Pharm.D., M.S., BCPS, CACP Capital Division Director of Clinical Pharmacy Department of Pharmacy Hospital Corporation of America/Central Atlantic Supply Chain Richmond, Virginia Marianne McCollum, Ph.D., BSPharm, BCPS Interim Dean School of Pharmacy Rueckert-Hartman College for Health Professions Regis University Denver, Colorado Meghan K. Sullivan, Pharm.D. Assistant Professor Department of Pharmacy Practice and Science University of Maryland School of Pharmacy Rockville, Maryland

Lynne M. Sylvia, Pharm.D. Senior Clinical Pharmacy Specialist Department of Pharmacy Tufts Medical Center Adjunct Clinical Professor School of Pharmacy Northeastern University Boston, Massachusetts The American College of Clinical Pharmacy and the authors thank the following individuals for their careful review of the Book 5, Chronic Illnesses II chapters: Dianne M. Brundage, Pharm.D., FCCP, BCPS, BCOP Oncology Clinical Pharmacy Specialist Park Nicollet Health Services Methodist Hospital Minneapolis, Minnesota Nicola G. Dahl, Pharm.D. Medical Writer Kanab, Utah Mary Lee, Pharm.D., FCCP, BCPS Vice President and Chief Academic Officer Pharmacy and Health Sciences Education Midwestern University Professor of Pharmacy Practice Midwestern University Chicago College of Pharmacy Downers Grove, Illinois

Skin Disorders

Authors Teresa M. Bailey, Pharm.D., FCCP, BCPS Professor Department of Pharmacy Practice Ferris State University College of Pharmacy Kalamazoo, Michigan Jodie L. Elder, Pharm.D., BCPS Assistant Professor Department of Pharmacy Practice Ferris State University Grand Rapids, Michigan Reviewers Elizabeth A. Boucher, Pharm.D., BCPS Clinical Pharmacist Concord Hospital Concord, New Hampshire Marisel Segarra-Newnham, Pharm.D., MPH, FCCP, BCPS Clinical Pharmacy Specialist, Infectious Diseases Pharmacy Service Veterans Affairs Medical Center West Palm Beach, Florida Clinical Assistant Professor of Pharmacy Practice University of Florida College of Pharmacy Gainesville, Florida

Chronic Illnesses II


PSAP-VII · Chronic Illnesses

Consultancies: Marisa Battistella (Shire Pharmaceuticals); Elizabeth A. Boucher (Pediatric Pharmacy Advocacy Group); Kimberli M. Burgner (Hospital Corporation of America, Clinical Pharmacy Advisory Board); Steven Dunn (Cardea Rx/Johnson & Johnson); Michael E. Ernst (Takeda Pharmaceuticals); Shannon W. Finks (Novartis Pharmaceuticals); Christa M. George (Bayer, Ortho McNeil); Gloria Grice ( Johnson & Johnson); Henry Halapy (Merck Frosst Canada, Ltd); Brian A. Hemstreet (Conexus Health); Lisa C. Hutchison (Arkansas Medicaid, Arkansas Foundation for Medical Care); Melanie S. Joy (National Institutes of Health, Fleet Laboratories, FDA); Elaine H. Morrato (U.S. Food and Drug Administration); Kirsten Ohler (ACCP [three presentations]); Patricia H. Powell (South Carolina Pharmacy Association); Valerie Prince (American Pharmacists Association, Alabama Board of Pharmacy); Jane M. Pruemer (Hematology Oncology Pharmacy Association); Michelle Richardson (Amgen, QualityMetric); Marisel Segarra-Newnham (Tibotec Therapeutics, USP, Annals of Pharmacotherapy); Jeffrey T. Sherer (Sturge-Weber Foundation); Jaekyu Shin (University of California­San Diego) Stock Ownership: Katherine H. Chessman (Procter & Gamble [spouse or significant other]); Lisa C. Hutchison (Cardinal Health); Melanie S. Joy (Katharos, Inc.); Emilie Karpiuk (Cardinal Health); Elaine H. Morrato ­ (Procter & Gamble [self]), Oncology Biotech Co. [spouse or significant other]) Royalties: Larisa H. Cavallari (Lexicomp, Inc.) Lisa C. Hutchison (ASHP); Melanie S. Joy (University of North Carolina); Jane M. Pruemer (ASHP); Lynne M. Sylvia ( Jones and Bartlett Publishing)

Disclosure of Potential Conflicts of Interest

Grants: Larisa H. Cavallari (NIH, American Heart Association); Lisa B. Cohen (ASHP); Honoraria (Massachusetts Association of Health System Pharmacists; Connecticut Pharmacist Association); Gloria Grice (National Institutes of Health); Henry Halapy (Novo Nordisk Canada, Inc.); Brian A. Hemstreet (AstraZeneca); Anne L. Hume (AHRQ [two grants], HRSA); Lisa C. Hutchison (Boehringer Ingelheim, National Institutes of Health); Melanie S. Joy (National Institutes of Health, ACCP, Roche, University of North Carolina); Elaine H. Morrato (The Children's Hospital Research Institute, Pfizer, Eli Lilly); Michelle Richardson (NIH NIDDK [two grants]); Jaekyu Shin (University of California ­ San Francisco); Meghan K. Sullivan (American Foundation for Pharmaceutical Education/ National Association of Chain Drug Stores Foundation); Patricia R. Wigle (Novartis, University of Cincinnati Health-UC [two grants]) Honoraria: Marisa Battistella (Shire Pharmaceuticals, Amgen); Jodie L. Elder (Michigan Pharmacists Association); Henry Halapy (Sanofi Aventis Canada, Inc.); Lisa C. Hutchison (ACCP, ASHP); Matt Kauflin (Cubist Pharmaceuticals, AstraZeneca); Patricia H. Powell (South Carolina Pharmacy Association); Jane M. Pruemer (Curatio CME Institute, HOPA, Amgen); Michelle Richardson (Amgen); Tricia M. Russell (AstraZeneca, APhA); Jaekyu Shin (ACCP) Other: Nothing to Disclose: Teresa M. Bailey, Christopher Bernheisel, Leonardo R. Brandao, Kristen Bova Campbell, Clarence Chant, Bradley E. Hein, Brandi C. LaFrance, Marianne McCollum, Michael Remkus, Jo Ellen Rodgers, Beth A. Sproule, Kathryn Timberlake, Sarah Tomasello, Kimberly Metka Welch

ROLE OF ACCP: ACCP developed the petition seeking recognition of Pharmacotherapy as a specialty of pharmacy and presented it to the Board of Pharmacy Specialties (BPS). As part of its mission to provide leadership, education, advocacy, and resources enabling clinical pharmacists to achieve excellence in practice and research, ACCP also helps pharmacotherapy specialists maintain their certification through PSAP. ACCP reports successful completion of PSAP examinations to BPS for recertification credit. Neither ACCP nor its agents, including the PSAP Editorial Board, authors, reviewers, or other staff, has knowledge of specific examination content, areas of emphasis, or any other information that would compromise the integrity of the examination process.

ROLE OF BPS: The Board of Pharmacy Specialties (BPS) is an autonomous division of the American Pharmacists Association (APhA). BPS is totally separate and distinct from ACCP. The Board, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. PSAP has been approved by BPS for use in BCPS recertification. Information about the BPS recertification process is available at Other questions regarding recertification should be directed to:

Board of Pharmacy Specialties 2215 Constitution Avenue NW Washington, DC 20037 (202) 429-7591

Front Matter


PSAP-VII · Chronic Illnesses


3 pages

Find more like this

Report File (DMCA)

Our content is added by our users. We aim to remove reported files within 1 working day. Please use this link to notify us:

Report this file as copyright or inappropriate


You might also be interested in

Microsoft Word - Curriculum Vita newest version.doc
HP122-03-Review (07p).p65
Microsoft PowerPoint - AM09-pd_June_16_v3 [Read-Only]